galactosidase alpha
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La GLA gene provides instructions for making an enzyme called alpha-galactosidase A. This enzyme is active in lysosomes, which are structures that act as recycling centers within cells. Lysosomes use digestive enzymes to process worn-out cell components and recycle usable parts.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La GLA gene provides instructions for making an enzyme called alpha-galactosidase A. This enzyme is active in lysosomes, which are structures that act as recycling centers within cells. Lysosomes use digestive enzymes to process worn-out cell components and recycle usable parts.
Alpha-galactosidase A breaks down a molecule called globotriaosylceramide, which consists of three sugars attached to a fatty substance. This molecule is degraded as part of the normal recycling of old red blood cells (erythrocytes) and other types of cells.
Conditions referring to this gene or chromosome
Other names
AGAL_HUMAN
Agalsidase alfa
Alpha-D-galactosidase A
alpha-D-galactoside galactohydrolase
Alpha-galactosidase
alpha-Galactosidase A
ceramidetrihexosidase
GALA
galactosidase, alpha
Melibiase
Related patient information and medicines

Patient information leaflet
Insuffisance hépatique
Diseases of the veins in the liver Some diseases (for example, Budd-Chiari syndrom... Metabolic diseases Some rare metabolic diseases may cause acute liver failure. These include haemochromatosis Haemochromatosis , alpha-1 antitrypsin deficiency Alpha-1 antitrypsin deficiency , Wilson's disease Wilson's disease , fructose intolerance,.

Patient information leaflet
Cancer primitif du foie
Ceci est un rare cancer which occurs in some young children. Angiosarcoma . This is rare. It develops from blood vessel cells within the liver. See the separate leaflet called Cancer for more general information about cancer Cancer. Liver cancer symptoms There may be no symptoms in the early stage of the disease. As the cancer grows, the first.

Patient information leaflet
Cancer testiculaire
Cancer testiculaire est a cancer that arises from a testicle (testis). Around half of all cases occur in men aged under 35 but testicular cancer rarely occurs before puberty. Another useful test i... The marqueurs tumoraux commonly tested for are alpha-foetoprotéine (AFP), beta human chorionic gonadotrophin (beta-hCG), lactic dehydrogenase (LDH) and.

Patient information leaflet
Prostatite chronique
Prostatite means that you have inflammation of votre prostate gland. There are two main types of prostatitis: short-lived (acute) or persiste... It may be that some antibiotics have anti-inflammatory properties as well or that they may clear some germs (bacteria) that are difficult to find when your urine is tested. Alpha-blockers Alpha-blockers -.

Patient information leaflet
Tests de fonction hépatique
Tests de fonction hépatique are a set of blood tests commonly done to check on the health of your liver. Changes in liver function tests give a clue as to whether your liver is under strain, inflamed, infected or diseased, and how badly. The pattern of the liver function tests can give a clue to the cause and can allow early detection of unsuspected.

Patient information leaflet
Éruption polymorphe à la lumière
Éruption polymorphe à la lumière is a skin rash that can happen when you go out in the sun. Polymorphic light eruption symptoms Polymorphic light eruption (PMLE) is a rash which comes on after being in strong sunlight. It looks like reddened skin with raised red spots or small blisters. It is generally itchy and uncomfortable. It can feel sore or.
Lectures complémentaires et références
- galactosidase alpha; MedlinePlus, National Library of Medicine.
- Feldt-Rasmussen U, Rasmussen AK, Mersebach H, Rosenberg KM, Hasholt L, Sorensen SA. Fabry disease--a metabolic disorder with a challenge for endocrinologists? Horm Res. 2002;58(6):259-65. doi: 10.1159/000066443.
- Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004 Mar 19;337(2):319-35. doi: 10.1016/j.jmb.2004.01.035.
- Matsuzawa F, Aikawa S, Doi H, Okumiya T, Sakuraba H. Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes. Hum Genet. 2005 Aug;117(4):317-28. doi: 10.1007/s00439-005-1300-5. Epub 2005 May 28.
- Mehta A, Hughes DA. Fabry Disease. 2002 Aug 5 [updated 2024 Apr 11]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1292/
- Pastores GM, Lien YH. Biochemical and molecular genetic basis of Fabry disease. J Am Soc Nephrol. 2002 Jun;13 Suppl 2:S130-3. No abstract available.
- Schafer E, Baron K, Widmer U, Deegan P, Neumann HP, Sunder-Plassmann G, Johansson JO, Whybra C, Ries M, Pastores GM, Mehta A, Beck M, Gal A. Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Hum Mutat. 2005 Apr;25(4):412. doi: 10.1002/humu.9327.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

